Simcere Pharmaceutical, a manufacturer of branded generic pharmaceuticals for the Chinese market, filed for IPO Friday. Goldman Sachs is the sole bookrunner on the deal. Terms have not yet been announced.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
